Pertuzumab biosimilar(Zydus Cadila)
帕妥珠单抗生物类似药（Zydus Cadila）
Report date: 2022/07/04 19:38:02
Base Information
Drug NamePertuzumab biosimilar(Zydus Cadila)
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaN/A
Originator CompaniesZydus Cadila
China Registration ClassN/A
Develop Information
Active CompaniesZydus Lifesciences Ltd
Inactive CompaniesN/A
Active Indications
Inactive IndicationsN/A
Other Information
ATC CodeN/A
Related LinksN/A